doxapram has been researched along with a 1899 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bedoya, M; Decher, N; González, W; Kiper, AK; Ramírez, D; Rinné, S | 1 |
| Cotten, JF | 1 |
| Bhayana, B; Chokshi, RH; Cotten, JF; Larsen, AT | 1 |
1 review(s) available for doxapram and a 1899
| Article | Year |
|---|---|
TASK Channels Pharmacology: New Challenges in Drug Design.
Topics: Animals; Drug Design; Drug Discovery; Humans; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Tandem Pore Domain | 2019 |
2 other study(ies) available for doxapram and a 1899
| Article | Year |
|---|---|
TASK-1 (KCNK3) and TASK-3 (KCNK9) tandem pore potassium channel antagonists stimulate breathing in isoflurane-anesthetized rats.
Topics: Anesthesia, Inhalation; Anesthetics, Inhalation; Animals; Benzamides; Benzeneacetamides; Blood Gas Analysis; Blood Pressure; Doxapram; Indicators and Reagents; Injections, Intravenous; Isoflurane; Male; Nerve Tissue Proteins; Plethysmography; Potassium Channel Blockers; Potassium Channels, Tandem Pore Domain; Propiophenones; Rats; Rats, Sprague-Dawley; Respiration; Respiratory System Agents; Stimulation, Chemical | 2013 |
Breathing Stimulant Compounds Inhibit TASK-3 Potassium Channel Function Likely by Binding at a Common Site in the Channel Pore.
Topics: Amino Acid Sequence; Animals; Benzamides; Benzeneacetamides; Binding Sites; Cells, Cultured; Doxapram; Molecular Docking Simulation; Molecular Sequence Data; Mutagenesis; Potassium Channels, Tandem Pore Domain; Rats; Rats, Inbred F344; Respiratory System Agents; Structure-Activity Relationship | 2015 |